To evaluate the peri-operative and renal functional outcomes of patients undergoing synchronous bilateral partial nephrectomy (PN) or percutaneous cryoablation (PCA).
Introduction
While the vast majority of patients with renal masses present with unilateral disease,~3% of patients are diagnosed with synchronous bilateral renal masses [1] [2] [3] ; however, the optimal treatment strategies for patients presenting with synchronous bilateral renal masses remains unknown. If technically feasible, bilateral partial nephrectomies (PNs) are often the preferred strategy because of the benefits of renal functional preservation when compared with radical nephrectomy. More recently, renal mass ablation has emerged as a treatment alternative for patients with renal masses [4] , but there are limited data on the extension of ablative techniques to the treatment of bilateral renal masses [5] .
The decision to perform bilateral procedures on the same day or in staged procedures is often based on surgeon preference. Operating on both kidneys on the same day has the potential benefits of eliminating the morbidity and risks of two separate operations; however, there is a potential risk of increased peri-operative surgical complications and significant detriments to renal function. To date, there are sparse data on the outcomes of patients undergoing synchronous bilateral nephron-sparing procedures. In the present paper, therefore, we report on the peri-operative and renal functional outcomes of patients undergoing same-day bilateral PN or percutaneous cryoablation (PCA) for bilateral renal masses.
Patients and Methods

Patient Selection and Management
After obtaining institutional review board approval, we retrospectively identified all patients who underwent bilateral PN or bilateral PCA on the same day at the Mayo Clinic. The years of inclusion of the registries for PN were 1974-2013 and for PCA they were 2003-2013. Patients were excluded if they had metastatic disease at the time of their procedure.
Our procedures for both PN and PCA have been previously described [6] [7] [8] . In general, for PN, the renal pedicle was first isolated and the surface of the kidney was then cleared of overlying fascia to allow inspection of the kidney. Both tumour enucleation and wedge resection techniques were variously employed. Intra-operative frozen-section analysis was routinely used to help ensure negative surgical margins were achieved. The type of incision for those who underwent an open procedural approach, the use of renal ischaemia and the use of renal cooling were at the discretion of the surgeon. Bilateral PCA was performed under either CT or ultrasonography guidance at the discretion of the radiologist.
Data Collection and Statistical Analysis
Clinical and pathological features for all patients were collected from our institutional nephrectomy and renal mass ablation registries for patients undergoing PN or PCA, respectively. Data in our nephrectomy registry are collected by a trained nurse abstractor from electronic medical records and through clinician and patient correspondence, with automatic data checks and periodic auditing. Data in our renal mass ablation registry are collected by clinicians through review of electronic medical records, with periodic auditing for tumour characteristics and oncological outcomes.
Estimated GFRs (eGFRs) were calculated at baseline, discharge and at 3 months follow-up using the Chronic Kidney Disease Epidemiology Collaboration formula [9] and expressed as mL/min/1.73 m 2 . The absolute change and percent change in eGFR from baseline to discharge and 3-month follow-up were recorded, calculated as discharge minus baseline and 3-month follow-up minus baseline. Complications were classified according the modified Clavien-Dindo classification [10] . Histological discordance was defined as more than one renal mass histological subtype present in an individual patient.
Clinical and pathological features are summarized with medians and interquartile ranges (IQRs) or frequency counts and percentages. Because of the limited number of patients undergoing PCA, statistical comparisons between the PN and PCA groups were not performed.
Results
Synchronous Bilateral Partial Nephrectomy
During the study period, 265 patients were treated surgically for synchronous bilateral renal masses, including 96 who were treated in a staged fashion and 169 who underwent synchronous bilateral procedures. Among those undergoing synchronous procedures, 17 underwent bilateral radical nephrectomy and 76 underwent unilateral PN and contralateral radical nephrectomy. The remaining 76 patients underwent synchronous bilateral PN and comprise the patients included in the present analysis.
The median (IQR) maximum tumour size for patients in the synchronous bilateral PN group was 4.6 (3.4, 6.5) cm. Bilateral renal ischaemia (hilar clamping) was performed in 22 patients (29.7%), including six (8.1%) who underwent bilateral renal cooling. Additionally, 29 patients (38.2%) underwent unilateral renal ischaemia, including 13 (17.1%) who underwent unilateral renal cooling. The median (IQR) hospital stay among the entire cohort was 7 (5, 8) days. Histological diagnosis was available for all 249 renal masses, and more than one histology was noted in 34 patients (44.7%). Among the 61 patients with RCC, nine were diagnosed with distant metastases, and eight had died from RCC at a median (IQR) follow-up of 3.2 (1.5-7.5) years. Clinical and pathological characteristics of patients undergoing synchronous bilateral PN are shown in Table 1 .
Overall, two patients underwent synchronous bilateral PN in the 1970s, five in the 1980s, 23 in the 1990s, 34 in the 2000s, and 12 between 2011 and 2013. When comparing clinical characteristics of patients treated before 2000 with those of patients treated in 2000 or after, no statistically significant differences were identified in patient age, Charlson comorbidity score, maximum tumour size, median number of tumours treated, or the use of bilateral cold ischaemia; however, patients treated before 2000 were significantly more likely to have undergone bilateral renal artery clamping (46.7 vs 18.2%; P = 0.009) and were more likely to be women (46.7% vs 17.4%; P = 0.006) than the more contemporary patients. The median (IQR) preoperative eGFR was 65 (52, 82) mL/min/1.73 m 2 for the PN group. The median (IQR) change in eGFR from baseline to discharge was À32 (À46, À15)% and from baseline to 3-month follow-up it was À9 (À19, 0)%. Eight patients were diagnosed with acute renal failure postoperatively (based on clinician documentation), with a median (IQR) change in eGFR from baseline to discharge of À58 (À67, À53)% and from baseline to 3-month follow-up of À23 (À26, À20)%. The median (IQR) hospital 244 © 2018 The Authors BJU International © 2018 BJU International stay among these eight patients was similar to that of the entire cohort (7 [6, 10] days). No patient required renal replacement therapy in the peri-operative period.
Information on postoperative complications was available for 74 patients (97.4%) undergoing synchronous bilateral PN. Of these, 16 (21.6%) experienced a total of 20 complications. Two patients (2.7%) in the PN group required angioembolization in the postoperative period: one for active bleeding and one for a pseudoaneurysm. Peri-operative outcomes for patients undergoing synchronous bilateral PN are shown in Table 2 .
A subgroup analysis was performed on patients who underwent bilateral renal artery clamping. Among these patients, the median (IQR) maximum tumour size was 5.3 (4.0, 6.8) cm and the median pre-operative eGFR was 61 (50, 79) mL/min/1.73 m 2 . The median (IQR) change in eGFR from baseline to discharge was À33 (À48, À25)%, and from baseline to 3-month follow-up it was À18 (À21, À10)%. Two of these patients developed acute renal failure in the perioperative period, but none required renal replacement therapy. Clinical and pathological characteristics as well as peri-operative outcomes for patients in this subgroup are shown in Tables S1 and S2, respectively.
Synchronous Bilateral Percutaneous Cryoablation
A total of 12 patients underwent synchronous bilateral PCA for a total of 28 renal masses during the study period. One patient in this group underwent bilateral PCA on two separate occasions, giving a total of 13 procedures included in the present report. Histological diagnosis was available for 21 renal masses (75%), with two different histologies noted in two patients. No patient developed metastatic RCC during a median (IQR) follow-up of 1.2 (0.3, 3.6) years. Table 3 shows baseline clinical and pathological characteristics for patients undergoing synchronous bilateral PCA.
The median (IQR) pre-operative eGFR was 67 (51, 89) mL/min/1.73 m 2 for patients undergoing PCA. The median (IQR) change in eGFR from baseline to discharge was À17 (À33, À3)% and from baseline to 3-month follow-up it was À8 (À11, 15)%. No patient in the PCA group required renal replacement therapy within 3 months of follow-up.
Information on postoperative complications was available for all 13 PCA procedures. After PCA, four patients (30.8%) experienced a total of five complications. One patient in the PCA group required postoperative angioembolization for active bleeding and one patient with multiple comorbidities IQR, interquartile range. died 20 days after PCA from sepsis (it was unknown if this was related to the procedure). Peri-operative outcomes for patients undergoing synchronous bilateral PCA are shown in Table 4 .
Discussion
In the present study, we examined the peri-operative outcomes of patients undergoing synchronous bilateral PN or PCA. We found that neither synchronous bilateral PN nor PCA resulted in large declines in renal function, with none of our patients requiring renal replacement therapy in the perioperative period. In addition, we identified that between onequarter and one-third of patients experienced a complication after synchronous bilateral procedures. We conclude that synchronous bilateral nephron-sparing procedures, when feasible, are acceptable treatment options for patients presenting with synchronous bilateral renal masses.
Several small series have previously reported on the surgical management of patients with bilateral renal masses [1, 3, [11] [12] [13] [14] [15] ; however, the currently available studies focus on all patients undergoing bilateral treatments for renal masses, including both synchronous and staged procedures and both radical and partial nephrectomies. Overall, there are limited data on patients undergoing synchronous bilateral PN. In addition, only one previous study has reported on the use of renal mass ablation for the treatment of bilateral renal masses [5] . As such, the present study provides novel data on outcomes of patients with such bilateral renal tumours.
As expected, the effects on renal function of synchronous bilateral procedures appear to be greater than the effects of a unilateral procedure [15] . A recent study from our institution described minimal change in renal function postoperatively in patients undergoing unilateral PN or PCA [15] . By contrast, in the present study, we found moderate declines in renal function of À32% and À17% for patients undergoing bilateral PN or PCA. Importantly, however, none of the patients in either group progressed after the procedure to severe acute renal failure requiring renal replacement therapy. In addition, a substantial improvement in renal function towards baseline was noted by 3-month follow-up. Although based on small numbers, our results suggest that synchronous bilateral nephron-sparing procedures can be performed in select patients without undue concern for the effects on renal function. Notably, however, the median baseline eGFR in the present study was~65 mL/min/1.73 m 2 in both groups of patients; thus, these results might not be generalizable to patients with poorer renal function. In such patients, staged procedures may decrease the risk of acute renal failure. Furthermore, in this subset of patients, and in those with significant comorbidities, active surveillance of one or both sides may be an appropriate treatment in order to limit the impact on renal function and the morbidity of treatment.
There are several well-known complications of both PN and PCA [16, 17] . Indeed, the potential for an increased proportion and severity of complications when performing bilateral synchronous procedures may be a concern, particularly with regard to the increased risk of postoperative renal haemorrhage; however, the complication rates reported in the present study are generally in line with previous series reporting complications for patients undergoing unilateral procedures [16] . Indeed, a recent study from our institution identified an overall complication rate of 14% after unilateral PN, in comparison with 22% in the present study for patients who underwent PN [16] . Although the complication rate in the present study among patients in the bilateral PCA group was slightly higher, at 31%, the low number of patients makes this a potentially spurious finding. We conclude that the risk of complications, although slightly higher than those reported in patients undergoing unilateral procedures, should not be a deterrent from performing synchronous bilateral procedures.
The present study has several limitations that warrant discussion. First, there was probably a selection bias with regard to which patients were chosen for synchronous bilateral procedures; patients in the present study had relatively small renal masses and our results may not be applicable to patients undergoing bilateral PN or PCA for larger renal masses. Second, patients who were scheduled to undergo bilateral procedures but in whom treatment of the second side was aborted were not included in the analysis. Third, the small number of patients in the PCA group limits our ability to perform comparative analyses between bilateral PN and bilateral PCA; however, the aim of the present study was to report on the peri-operative outcomes of each of these procedures and not to investigate the superiority of one approach over the other. Fourth, there was no comparison with patients undergoing non-synchronous procedures, although multiple previous studies have reported outcomes of these procedures. Fifth, all of the procedures were performed at a high-volume centre and the results may not be applicable to patients treated at lower-volume centres. Finally, all but one of the synchronous bilateral PNs were performed using an open surgical approach, and our results may not be comparable with results for patients undergoing bilateral minimally invasive surgery in either a synchronous or staged fashion. These limitations notwithstanding, we believe the present results support the use of synchronous bilateral PN or PCA in select patients presenting with bilateral renal masses.
In conclusion, in a cohort of patients undergoing synchronous bilateral PN or PCA, we found that the risk of acute renal failure was low, with no patient requiring renal replacement therapy in the peri-operative period. Furthermore, one-quarter of patients in the PN group and one-third of those in the PCA group experienced perioperative complications. For select patients presenting with bilateral renal masses, synchronous bilateral PN or PCA appear to be acceptable treatment options.
Abbreviations: eGFR, estimated GFR; IQR, interquartile range; PCA, percutaneous cryoablation; PN, partial nephrectomy.
Supporting Information
Additional Supporting Information may be found in the online version of this article: 
